Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Margaretha Rudas"'
Autor:
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler, Florian Fitzal
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-14 (2023)
Abstract Background Epirubicin/cyclophosphamide (EC) and docetaxel (D) are commonly used in a sequential regimen in the neoadjuvant treatment of early, high-risk or locally advanced breast cancer (BC). Novel approaches to increase the response rate c
Externí odkaz:
https://doaj.org/article/472702d7c4da4a55985a14b3016a1c91
Autor:
Sabine Danzinger, Yen Yen Tan, Margaretha Rudas, Marie-Theres Kastner, Sigrid Weingartshofer, Daniela Muhr, Christian F. Singer
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background It is important to identify biomarkers associated with BRCA mutation in women with early breast cancer (BC) to improve early identification of mutation carriers. Thus, in this study, we examined the protein expression of claudin (
Externí odkaz:
https://doaj.org/article/a06f654a3ebf48279c9254127e383cce
Autor:
Christian F. Singer, Frederik Holst, Stefan Steurer, Eike Burandt, Sigurd Lax, Raimund Jakesz, Margaretha Rudas, Herbert Stöger, Richard Greil, Guido Sauter, Martin Filipits, Ronald Simon, Michael Gnant
Publikováno v:
Cancer Research. 83:P2-11
Purpose: Estrogen receptor (ER) expression predicts response to endocrine therapy and is a prognostic biomarker. However, no ER-associated biomarker is able to identify patients with particularly favorable outcome among ER+ tumors. We investigated th
Autor:
Christian F, Singer, Frederik, Holst, Stefan, Steurer, Eike C, Burandt, Sigurd F, Lax, Raimund, Jakesz, Margaretha, Rudas, Herbert, Stöger, Richard, Greil, Guido, Sauter, Martin, Filipits, Ronald, Simon, Michael, Gnant
Publikováno v:
Clinical Cancer Research. 28:4112-4120
Purpose: Estrogen receptor (ER) expression is a prognostic parameter in breast cancer, and a prerequisite for the use of endocrine therapy. In ER+ early breast cancer, however, no receptor-associated biomarker exists that identifies patients with a p
Autor:
Michael Gnant, Mathias Gehrmann, Ralf Kronenwett, Guido Hennig, Inke S. Feder, Karsten E. Weber, Peter Fritz, Matthias Schwab, Hiltrud Brauch, Werner Schroth, Manfred Kaufmann, Achim Rody, Heinz Kölbl, Marcus Schmidt, Fritz Jänicke, Volkmar Müller, Christa Freibauer, Paul Sevelda, Andrea Jelen, Richard Greil, Otto Dietze, Christian F. Singer, Florian Fitzal, Peter Dubsky, Raimund Jakesz, Margaretha Rudas, Martin Filipits
PDF file - 299K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16d9f1e992a0a0b58b9afe181fc3478
https://doi.org/10.1158/1078-0432.22442498
https://doi.org/10.1158/1078-0432.22442498
Autor:
Peter Dubsky, Michael Gnant, Dominik Hlauschek, William M. Gallagher, Des O'Leary, Tony Loughman, Stephen Barron, Daniel Egle, Wolfgang Hulla, Stefan Halper, Peter Regitnig, Marija Balic, Richard Greil, Zsuzsanna Bago-Horvath, Florian Fitzal, Christian F. Singer, Verena Kainz, Margaretha Rudas, Martin Filipits
Supplementary Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028786ad6de0561aa59b3d3a3deb75bd
https://doi.org/10.1158/1078-0432.22480376
https://doi.org/10.1158/1078-0432.22480376
Autor:
Peter Dubsky, Michael Gnant, Dominik Hlauschek, William M. Gallagher, Des O'Leary, Tony Loughman, Stephen Barron, Daniel Egle, Wolfgang Hulla, Stefan Halper, Peter Regitnig, Marija Balic, Richard Greil, Zsuzsanna Bago-Horvath, Florian Fitzal, Christian F. Singer, Verena Kainz, Margaretha Rudas, Martin Filipits
Main clinical and laboratory parameters of trial patients with or without tumor blocks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298b97e0cc2612e4dc8b9c507e700d15
https://doi.org/10.1158/1078-0432.22480373.v1
https://doi.org/10.1158/1078-0432.22480373.v1
Autor:
Rupert Bartsch, Matthias Preusser, Guenther G. Steger, Christoph C. Zielinski, Michael Gnant, Ruth Exner, Robert M. Mader, Karin Dieckmann, Zsuzsanna Bago-Horvath, Florian Fitzal, Margaretha Rudas, Mela Medjedovic, Anna S. Berghoff, Elisabeth S. Bergen
Patients characteristics of the overall population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df77acb13497ccdf4e13c64ebd90dc0
https://doi.org/10.1158/1078-0432.22472903
https://doi.org/10.1158/1078-0432.22472903
Autor:
Ellen Heitzer, Marija Balic, Michael Gnant, Martin Filipits, Nadia Dandachi, Sabrina Weber, Ricarda Graf, Anders Ståhlberg, Margaretha Rudas, Christian Fesl, Zsuzsanna Bago-Horvath, Peter C. Dubsky, Edgar Petru, Angelika Pichler, Viktor Wette, Rupert Bartsch, Georg Pfeiler, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Sophie Frantal, Simon P. Gampenrieder, Qing Zhou
Purpose:Accurate response assessment during neoadjuvant systemic treatment (NST) poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response based on cell-free circulating tumor DNA (ctDNA) may be beneficial to guide trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ed243da79c1c37626cfbc7ae763edc
https://doi.org/10.1158/1078-0432.c.6532496
https://doi.org/10.1158/1078-0432.c.6532496
Autor:
Michael Gnant, Martin Filipits, Zsuzsanna Bago-Horvath, Marija Balic, Ruth Exner, Michael Seifert, David Fuchs, Kristina A. Tendl, Rupert Bartsch, Edgar Petru, Christine Gruber, Farid Moinfar, Margaretha Rudas, Angelika Reiner, Daniel Egle, Guenther G. Steger, Florian Fitzal, Yen Y. Tan, Christian F. Singer
Supplemental Table 1. ypT0+ypN0 vs. HER2 ratios Supplemental Table 2. ypT0is+ypN0 vs. HER2 ratios Supplemental Table 3. ypT0is vs. HER2 ratios
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c797fd3b268c1fa8782ec9f17f4e6dcb
https://doi.org/10.1158/1078-0432.22465703
https://doi.org/10.1158/1078-0432.22465703